• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型有晶状体眼屈光晶状体设计的体内安全性长期观察

Long-term observation of the in vivo safety of a new design of phakic refractive lens.

作者信息

Jiang Yinjie, Chen Xun, Cheng Mingrui, Lin I-Chun, Li Boliang, Zhu Xinjie, Xu Guanghan, Miao Huamao, Wang Xiaoying, Zhou Xingtao

机构信息

Fudan University Eye Ear Nose and Throat Hospital, Shanghai, China.

Key laboratory of Myopia and Related Eye Diseases, National Health Commission, Shanghai, China.

出版信息

BMC Ophthalmol. 2025 Jan 7;25(1):10. doi: 10.1186/s12886-024-03803-0.

DOI:10.1186/s12886-024-03803-0
PMID:39773390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11705939/
Abstract

BACKGROUND

To evaluate the biosafety, reduction in anterior capsule opacification, and fluctuation in intraocular pressure (IOP) of a new phakic refractive lens (PRL) with a sinusoidal drainage groove design.

METHODS

This self-controlled experiment was performed on eight eyes of four rabbits. Each rabbit was implanted with a sinusoidal PRL (PRL-S5) in the right eye and a conventional posterior chamber PRL (PC-PRL) in the left eye. Slit-lamp examinations, optical coherence tomography, and IOP evaluation were performed before surgery and at 1 day, 1 week, 3 months, 6 months, and 1 year postoperatively in each eye. Gross examination, histopathology, and electron microscopy of the capsule and PRL were performed 1 year postoperatively.

RESULTS

On slit-lamp examination, the inflammatory reactions recovered one week after surgery. The PC-PRL group developed anterior subcapsular cataracts at 3 months postoperatively and diffuse and dense opacification of the cortex at 1 year. PRL-S5 showed mild local opacification in the optical zone 6 months postoperatively, which did not progress significantly. At 1 year, PC-PRLs had greater opacification (27.37-72.17%) than PRL S5 (6.63-66.96%). Three months after surgery, one eye in the PC-PRL group had scleral staphyloma, one eye had corneal edema, and one eye experienced nasal hepatic prolapse into the anterior chamber. One eye in the PRL-S5 group had papillary membranes but recovered 6 months postoperatively. Histopathological examination revealed liquefaction and necrosis of the opacified area in the center of the subcapsular membrane in both groups. Numerous granular bodies and fibrous precipitates were observed in epithelial cells in the opaque area. Electron microscopy showed that epithelial cells proliferated on the surface of all anterior capsule membranes, with no significant differences between the two groups. The capsular PC-PRL group showed anterior cortical proliferation and fibrosis. An IOP elevation was noted on the first postoperative day (18.8 to 37.9 mmHg). However, both the PC-PRL and PRL-S5 groups exhibited relatively stable IOP levels 1 week, 3 months, 6 months, and 1 year postoperatively.

CONCLUSIONS

The new PRL exhibited robust long-term biocompatibility. The sinusoidal groove design facilitated the maintenance of IOP stability without necessitating iridectomy and effectively mitigated the onset and progression of cataracts.

摘要

背景

评估一种具有正弦引流槽设计的新型有晶状体眼屈光晶状体(PRL)的生物安全性、前囊膜混浊程度的降低情况以及眼内压(IOP)的波动。

方法

本自我对照实验在4只兔子的8只眼睛上进行。每只兔子右眼植入正弦PRL(PRL-S5),左眼植入传统后房型PRL(PC-PRL)。在手术前以及术后第1天、1周、3个月、6个月和1年对每只眼睛进行裂隙灯检查、光学相干断层扫描和IOP评估。术后1年对晶状体囊膜和PRL进行大体检查、组织病理学检查和电子显微镜检查。

结果

裂隙灯检查显示,术后1周炎症反应消退。PC-PRL组术后3个月出现前囊下白内障,术后1年皮质出现弥漫性致密混浊。PRL-S5术后6个月在光学区出现轻度局部混浊,且未显著进展。术后1年,PC-PRL的混浊程度(27.37%-72.17%)高于PRL-S5(6.63%-66.96%)。术后3个月,PC-PRL组1只眼睛出现巩膜葡萄肿,1只眼睛出现角膜水肿,1只眼睛出现鼻侧虹膜脱垂至前房。PRL-S5组1只眼睛出现瞳孔膜,但术后6个月恢复。组织病理学检查显示两组晶状体囊膜下中央混浊区域均有液化和坏死。在混浊区域的上皮细胞中观察到大量颗粒体和纤维沉淀物。电子显微镜检查显示所有前囊膜表面上皮细胞均有增殖,两组之间无显著差异。PC-PRL组晶状体囊膜显示前皮质增殖和纤维化。术后第1天IOP升高(18.8至37.9 mmHg)。然而,PC-PRL组和PRL-S5组术后1周、3个月、6个月和1年的IOP水平均相对稳定。

结论

新型PRL具有良好的长期生物相容性。正弦槽设计有助于维持IOP稳定,无需行虹膜切除术,并有效减轻白内障的发生和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/e8eae23fb65d/12886_2024_3803_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/ee14dc79d110/12886_2024_3803_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/96669f8cd6b0/12886_2024_3803_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/acf923d5c064/12886_2024_3803_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/1ecbe6a4a0f9/12886_2024_3803_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/e8eae23fb65d/12886_2024_3803_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/ee14dc79d110/12886_2024_3803_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/96669f8cd6b0/12886_2024_3803_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/acf923d5c064/12886_2024_3803_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/1ecbe6a4a0f9/12886_2024_3803_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3773/11705939/e8eae23fb65d/12886_2024_3803_Fig5_HTML.jpg

相似文献

1
Long-term observation of the in vivo safety of a new design of phakic refractive lens.新型有晶状体眼屈光晶状体设计的体内安全性长期观察
BMC Ophthalmol. 2025 Jan 7;25(1):10. doi: 10.1186/s12886-024-03803-0.
2
Assessment of biosafety and implantation feasibility of novel phakic refractive lens.新型有晶状体眼屈光性透镜的生物安全性和植入可行性评估。
Int Ophthalmol. 2022 Nov;42(11):3459-3468. doi: 10.1007/s10792-022-02345-y. Epub 2022 May 13.
3
Clinical outcomes of phakic refractive lens in myopic and hyperopic eyes: 1-year results.有晶状体眼近视和远视屈光性晶状体植入术的临床疗效:1 年结果。
J Cataract Refract Surg. 2005 Jun;31(6):1145-52. doi: 10.1016/j.jcrs.2004.11.059.
4
Cloudy complication: management of an opacified intraocular lens and diffuse iris transillumination defects: August consultation #1.混浊并发症:混浊人工晶状体和弥漫性虹膜光透射缺陷的处理:8 月会诊 1 号。
J Cataract Refract Surg. 2020 Aug;46(8):1202. doi: 10.1097/j.jcrs.0000000000000330.
5
Posterior chamber phakic intraocular lens to correct myopia: long-term follow-up.后房型有晶状体眼人工晶状体矫正近视:长期随访。
J Cataract Refract Surg. 2013 Jul;39(7):1023-8. doi: 10.1016/j.jcrs.2013.01.041. Epub 2013 May 8.
6
Evaluation of stability and capsular bag opacification of a new foldable adjustable intraocular lens.新型可折叠可调节人工晶状体的稳定性及囊袋混浊情况评估
Clin Exp Ophthalmol. 2015 Sep-Oct;43(7):648-54. doi: 10.1111/ceo.12526. Epub 2015 May 13.
7
Cataractous changes due to posterior chamber flattening with a posterior chamber phakic intraocular lens secondary to the administration of pilocarpine.由于使用毛果芸香碱后后房型有晶状体眼人工晶状体导致后房变平而引起的白内障改变。
Ophthalmology. 2006 Aug;113(8):1283-8. doi: 10.1016/j.ophtha.2006.03.053. Epub 2006 Jun 12.
8
New posterior chamber phakic intraocular lens for high myopia: three-year results.用于高度近视的新型后房型有晶状体眼人工晶状体:三年随访结果
J Cataract Refract Surg. 2015 Aug;41(8):1610-5. doi: 10.1016/j.jcrs.2014.11.052.
9
Phakic refractive lens: two-year results.有晶状体眼屈光性晶状体:两年结果
J Refract Surg. 2008 May;24(5):507-15. doi: 10.3928/1081597X-20080501-09.
10
Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.用于治疗屈光不正的有晶状体眼人工晶状体:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(14):1-120. Epub 2009 Oct 1.

本文引用的文献

1
Prevalence and association of uncorrected refractive error among Chinese adolescents: a cross-sectional study.中国青少年未矫正屈光不正的患病率及相关性:一项横断面研究。
BMC Public Health. 2024 Oct 21;24(1):2904. doi: 10.1186/s12889-024-20387-y.
2
Effects of intraocular pressure change on intraocular lens power calculation in primary open-angle glaucoma and ocular hypertension.眼压变化对原发性开角型青光眼和高眼压症眼内晶状体屈光力计算的影响。
PLoS One. 2024 Jun 10;19(6):e0304169. doi: 10.1371/journal.pone.0304169. eCollection 2024.
3
A Review of Intraocular Lens Power Calculation Formulas Based on Artificial Intelligence.
基于人工智能的人工晶状体屈光力计算公式综述
J Clin Med. 2024 Jan 16;13(2):498. doi: 10.3390/jcm13020498.
4
Animal Models for the Study of Keratoconus.用于研究圆锥角膜的动物模型。
Cells. 2023 Nov 22;12(23):2681. doi: 10.3390/cells12232681.
5
Intraocular Lens Power Calculation Formulas-A Systematic Review.人工晶状体屈光度计算公式——系统评价
Ophthalmol Ther. 2023 Dec;12(6):2881-2902. doi: 10.1007/s40123-023-00799-6. Epub 2023 Sep 12.
6
Temporal and spatial characterization of myopia in China.中国近视的时空特征。
Front Public Health. 2022 Aug 16;10:896926. doi: 10.3389/fpubh.2022.896926. eCollection 2022.
7
Assessment of biosafety and implantation feasibility of novel phakic refractive lens.新型有晶状体眼屈光性透镜的生物安全性和植入可行性评估。
Int Ophthalmol. 2022 Nov;42(11):3459-3468. doi: 10.1007/s10792-022-02345-y. Epub 2022 May 13.
8
A Comprehensive Investigation of Contrast Sensitivity and Disk Halo in High Myopia Treated With SMILE and EVO Implantable Collamer Lens Implantation.SMILE 和 EVO 可植入 Collamer 透镜植入治疗高度近视的对比敏感度和盘晕的综合研究。
Transl Vis Sci Technol. 2022 Apr 1;11(4):23. doi: 10.1167/tvst.11.4.23.
9
Assessment of the accuracy of new and updated intraocular lens power calculation formulas in 10 930 eyes from the UK National Health Service.评估英国国家医疗服务体系 10930 只眼中新型和更新的人工晶状体计算公式的准确性。
J Cataract Refract Surg. 2020 Jan;46(1):2-7. doi: 10.1016/j.jcrs.2019.08.014.
10
The epidemics of myopia: Aetiology and prevention.近视的流行:病因与预防。
Prog Retin Eye Res. 2018 Jan;62:134-149. doi: 10.1016/j.preteyeres.2017.09.004. Epub 2017 Sep 23.